BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 19111629)

  • 1. The cognitive and psychomotor effects of remacemide and carbamazepine in newly diagnosed epilepsy.
    Wesnes KA; Edgar C; Dean AD; Wroe SJ
    Epilepsy Behav; 2009 Mar; 14(3):522-8. PubMed ID: 19111629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of major antiepileptic drugs on attention, reaction time, and speed of information processing: results from a randomized, double-blind, placebo-controlled withdrawal study of seizure-free epilepsy patients receiving monotherapy.
    Hessen E; Lossius MI; Reinvang I; Gjerstad L
    Epilepsia; 2006 Dec; 47(12):2038-45. PubMed ID: 17201701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: pooled analysis of two long-term, randomized, follow-up studies.
    Aikiä M; Jutila L; Salmenperä T; Mervaala E; Kälviäinen R
    Epilepsia; 2006 Jul; 47(7):1121-7. PubMed ID: 16886974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study].
    Hernández R; Fernández Mde L; Miranda G; Suástegui R
    Rev Invest Clin; 2005; 57(4):522-31. PubMed ID: 16315636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of major antiepileptic drugs on neuropsychological function: results from a randomized, double-blind, placebo-controlled withdrawal study of seizure-free epilepsy patients on monotherapy.
    Hessen E; Lossius MI; Reinvang I; Gjerstad L
    J Int Neuropsychol Soc; 2007 May; 13(3):393-400. PubMed ID: 17445287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remacemide hydrochloride as an add-on therapy in epilepsy: a randomized, placebo-controlled trial of three dose levels (300, 600 and 1200 mg/day) in a Q.I.D. regimen.
    Chadwick DW; Betts TA; Boddie HG; Crawford PM; Lindstrom P; Newman PK; Soryal I; Wroe S; Holdich TA
    Seizure; 2002 Mar; 11(2):114-23. PubMed ID: 11945098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EpiTrack: tracking cognitive side effects of medication on attention and executive functions in patients with epilepsy.
    Lutz MT; Helmstaedter C
    Epilepsy Behav; 2005 Dec; 7(4):708-14. PubMed ID: 16266826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consequences of antiepileptic drug withdrawal: a randomized, double-blind study (Akershus Study).
    Lossius MI; Hessen E; Mowinckel P; Stavem K; Erikssen J; Gulbrandsen P; Gjerstad L
    Epilepsia; 2008 Mar; 49(3):455-63. PubMed ID: 17888074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive effects of antiepileptic drug discontinuation.
    Gallassi R; Morreale A; Di Sarro R; Marra M; Lugaresi E; Baruzzi A
    Epilepsia; 1992; 33 Suppl 6():S41-4. PubMed ID: 1486836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of the effects of carbamazepine and the NMDA receptor antagonist remacemide on road tracking and car-following performance in actual traffic.
    Ramaekers G; Lamers J; Verhey F; Muntjewerff D; Mobbs E; Sanders N; Lewis M; Lockton A
    Psychopharmacology (Berl); 2002 Jan; 159(2):203-10. PubMed ID: 11862350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Remacemide versus Carbamazepine in Newly Diagnosed Epilepsy: Comparison by Sequential Analysis.
    Brodie MJ; Wroe SJ; Dean AD; Holdich TA; Whitehead J; Stevens JW
    Epilepsy Behav; 2002 Apr; 3(2):140-146. PubMed ID: 12609415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term safety and efficacy of zonisamide versus carbamazepine monotherapy for treatment of partial seizures in adults with newly diagnosed epilepsy: results of a phase III, randomized, double-blind study.
    Baulac M; Patten A; Giorgi L
    Epilepsia; 2014 Oct; 55(10):1534-43. PubMed ID: 25109239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A placebo-controlled, double-blind cross-over trial of adjunctive one month remacemide hydrochloride treatment in patients with refractory epilepsy.
    Richens A; Mawer G; Crawford P; Harrison B
    Seizure; 2000 Dec; 9(8):537-43. PubMed ID: 11162750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of levetiracetam on cognitive functions and quality of life: a one-year follow-up study.
    López-Góngora M; Martínez-Domeño A; García C; Escartín A
    Epileptic Disord; 2008 Dec; 10(4):297-305. PubMed ID: 19017572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remacemide hydrochloride as an add-on therapy in epilepsy: a randomized, placebo-controlled trial of three dose levels (300, 600 and 800 mg/day) in a B.I.D. regimen.
    Jones MW; Blume WT; Guberman A; Lee MA; Pillay N; Weaver DF; Veloso F; Holdich TA
    Seizure; 2002 Mar; 11(2):104-13. PubMed ID: 11945097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled pilot study of vigabatrin versus carbamazepine monotherapy in newly diagnosed patients with epilepsy: an interim report.
    Kälviäinen R; Aikiä M; Partanen J; Sivenius J; Mumford J; Saksa M; Riekkinen PJ
    J Child Neurol; 1991; Suppl 2():S60-9. PubMed ID: 1940126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological and neurophysiologic effects of carbamazepine and levetiracetam.
    Meador KJ; Gevins A; Loring DW; McEvoy LK; Ray PG; Smith ME; Motamedi GK; Evans BM; Baum C
    Neurology; 2007 Nov; 69(22):2076-84. PubMed ID: 18040014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isobolographic analysis of interactions between remacemide and conventional antiepileptic drugs in the mouse model of maximal electroshock.
    Borowicz KK; Malek R; Luszczki JJ; Ratnaraj N; Patsalos PN; Czuczwar SJ
    Epilepsy Behav; 2007 Aug; 11(1):6-12. PubMed ID: 17602881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of tiagabine monotherapy on cognition and mood in adult patients with chronic partial epilepsy.
    Aikiä M; Jutila L; Salmenperä T; Mervaala E; Kälviäinen R
    Epilepsy Behav; 2006 Jun; 8(4):750-5. PubMed ID: 16647884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.
    Baulac M; Brodie MJ; Patten A; Segieth J; Giorgi L
    Lancet Neurol; 2012 Jul; 11(7):579-88. PubMed ID: 22683226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.